CS168036B2 - - Google Patents

Info

Publication number
CS168036B2
CS168036B2 CS4540A CS454073A CS168036B2 CS 168036 B2 CS168036 B2 CS 168036B2 CS 4540 A CS4540 A CS 4540A CS 454073 A CS454073 A CS 454073A CS 168036 B2 CS168036 B2 CS 168036B2
Authority
CS
Czechoslovakia
Application number
CS4540A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of CS168036B2 publication Critical patent/CS168036B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CS4540A 1972-07-01 1973-06-25 CS168036B2 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6630172A JPS5512435B2 (cs) 1972-07-01 1972-07-01

Publications (1)

Publication Number Publication Date
CS168036B2 true CS168036B2 (cs) 1976-05-28

Family

ID=13311838

Family Applications (1)

Application Number Title Priority Date Filing Date
CS4540A CS168036B2 (cs) 1972-07-01 1973-06-25

Country Status (15)

Country Link
US (1) US3925357A (cs)
JP (1) JPS5512435B2 (cs)
AT (1) AT325206B (cs)
AU (1) AU469986B2 (cs)
BE (1) BE801588A (cs)
CA (1) CA996548A (cs)
CH (1) CH573435A5 (cs)
CS (1) CS168036B2 (cs)
DE (1) DE2332840A1 (cs)
FR (1) FR2190414B1 (cs)
GB (1) GB1386566A (cs)
HU (1) HU166029B (cs)
NL (1) NL7308048A (cs)
PL (1) PL92969B1 (cs)
SE (1) SE402916B (cs)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522148U (cs) * 1978-07-29 1980-02-13
MY133479A (en) * 2001-02-24 2007-11-30 Boehringer Ingelheim Pharma Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
US20030171424A1 (en) * 2002-03-07 2003-09-11 Lin Ai J. Intravenous formulation of artelinic acid for treatment of severe and complicated malaria
US7407955B2 (en) * 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US7501426B2 (en) * 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de) * 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
DE102005035891A1 (de) * 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
PE20110235A1 (es) 2006-05-04 2011-04-14 Boehringer Ingelheim Int Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
CN109503584A (zh) * 2006-05-04 2019-03-22 勃林格殷格翰国际有限公司 多晶型
MX2010001821A (es) * 2007-08-17 2010-03-10 Boehringer Ingelheim Int Derivados de purina para uso en el tratamiento de enfermedades relacionadas con fap.
PE20140960A1 (es) 2008-04-03 2014-08-15 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
PE20100156A1 (es) * 2008-06-03 2010-02-23 Boehringer Ingelheim Int Tratamiento de nafld
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
KR20190016601A (ko) 2008-08-06 2019-02-18 베링거 인겔하임 인터내셔날 게엠베하 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
ES2764251T3 (es) * 2008-08-15 2020-06-02 Boehringer Ingelheim Int Inhibidores de DPP-4 para uso en el tratamiento de curación de heridas en pacientes diabéticos
WO2010029089A2 (en) 2008-09-10 2010-03-18 Boehringer Ingelheim International Gmbh Combination therapy for the treatment of diabetes and related conditions
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
EP2382216A1 (en) 2008-12-23 2011-11-02 Boehringer Ingelheim International GmbH Salt forms of organic compound
TW201036975A (en) 2009-01-07 2010-10-16 Boehringer Ingelheim Int Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy
NZ599298A (en) 2009-11-27 2014-11-28 Boehringer Ingelheim Int Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin
KR101927068B1 (ko) 2010-05-05 2018-12-10 베링거 인겔하임 인터내셔날 게엠베하 체중 감소 치료에 후속하는 dpp-4 억제제에 의한 순차적 병용 요법
CN106975074A (zh) 2010-06-24 2017-07-25 勃林格殷格翰国际有限公司 糖尿病治疗
US9034883B2 (en) 2010-11-15 2015-05-19 Boehringer Ingelheim International Gmbh Vasoprotective and cardioprotective antidiabetic therapy
ES2713566T3 (es) 2011-07-15 2019-05-22 Boehringer Ingelheim Int Derivado de quinazolina dimérico sustituido, su preparación y su uso en composiciones farmacéuticas para el tratamiento de la diabetes de tipo I y II
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
EP3685839A1 (en) 2012-05-14 2020-07-29 Boehringer Ingelheim International GmbH Linagliptin for use in the treatment of albuminuria and kidney related diseases
EP4151218A1 (en) 2012-05-14 2023-03-22 Boehringer Ingelheim International GmbH Linagliptin, a xanthine derivative as dpp-4 inhibitor, for use in the treatment of sirs and/or sepsis
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
US9526728B2 (en) 2014-02-28 2016-12-27 Boehringer Ingelheim International Gmbh Medical use of a DPP-4 inhibitor
EP4233840A3 (en) 2016-06-10 2023-10-18 Boehringer Ingelheim International GmbH Combinations of linagliptin and metformin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1026793A (fr) * 1949-08-02 1953-05-04 American Cyanamid Co Procédé de préparation de sels de pénicilline
NL6803062A (cs) * 1967-03-10 1968-09-11
US3557094A (en) * 1968-01-05 1971-01-19 Pfizer & Co C Substituted alkyl esters of alpha-carboxy aryl penicillins
AT290728B (de) * 1968-09-28 1971-05-15 Takeda Chemical Industries Ltd Verfahren zur herstellung neuer penicilline

Also Published As

Publication number Publication date
JPS5512435B2 (cs) 1980-04-02
AT325206B (de) 1975-10-10
JPS4925121A (cs) 1974-03-06
NL7308048A (cs) 1974-01-03
PL92969B1 (cs) 1977-04-30
BE801588A (fr) 1973-12-28
AU5760073A (en) 1975-01-09
FR2190414B1 (cs) 1976-07-02
AU469986B2 (en) 1976-02-26
HU166029B (cs) 1974-12-28
DE2332840A1 (de) 1974-01-17
SE402916B (sv) 1978-07-24
CH573435A5 (cs) 1976-03-15
US3925357A (en) 1975-12-09
FR2190414A1 (cs) 1974-02-01
GB1386566A (en) 1975-03-12
CA996548A (en) 1976-09-07

Similar Documents

Publication Publication Date Title
FR2172136A1 (cs)
FR2190414B1 (cs)
FR2203812A1 (cs)
JPS4921686A (cs)
FR2188804A5 (cs)
FR2208262B1 (cs)
JPS5339377B2 (cs)
JPS4966352A (cs)
JPS4988354A (cs)
JPS493540A (cs)
JPS5123550Y2 (cs)
JPS5128226Y2 (cs)
JPS5138686B2 (cs)
JPS4958541U (cs)
JPS48100145U (cs)
JPS4962228U (cs)
CH569308A5 (cs)
CH560767A5 (cs)
CH561250A5 (cs)
CH561060A5 (cs)
CH562332A5 (cs)
CH562388A5 (cs)
CH562602A5 (cs)
NL7305034A (cs)
NL7302615A (cs)